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Abstract
Introduction: Recently, a non-invasive, continuous ventricular stroke volume monitoring system using skin
electrodes has been developed. In contrast to impedance-based methods, the new technique (ventricular field
recognition) enables measurement of changes in ventricular volume. A prototype using this new method was built
(the hemologic cardiac profiler, HCP) and validated against a reference method in a pig model during variations in
cardiac output.
Methods: In six Dalland pigs, cardiac output was simultaneously measured with the HCP (CO-HCP), and an
invasive ultrasonic flow-probe around the ascending aorta (CO-FP). Variations in CO were achieved by change in
ventricular loading conditions, cardiac pacing, and dobutamine administration. Data were analysed according to
Bland-Altman analysis and Pearson’s correlation.
Results: Pearson’s correlation between the CO-HCP and the CO-FP was r = 0.978. Bland-Altman analysis showed a
bias of - 0.114 L/minute, and a variability of the bias (2 standard deviations, 2SD) of 0.55 L/minute.
Conclusions: The results of the present study demonstrate that CO-HCP is comparable to CO-FP in an animal
model of cardiac output measurements during a wide variation of CO. Therefore, the HCP has the potential to
become a clinical applicable cardiac output monitor.
Introduction
Measurement of cardiac output (CO) is important in the
hemodynamic management of peri-operative and criti-
cally ill patients. Pulmonary artery thermodilution CO
monitoring using the pulmonary artery catheter is still
the clinical reference technique of CO-monitoring, but
has major disadvantages, mainly associated with the
h i g hi n v a s i v e n e s so ft h et e c h n i q u e[ 1 ] .T h e r ei san e e d
for a non-invasive, precise, continuous, and operator-
independent technique of CO measurement. During the
last years a number of minor-invasive or even non-inva-
sive techniques have been developed. Non-invasive
ultrasound Doppler techniques like transthoracic echo-
cardiography have been developed, but require skilled
operators, and, therefore, are not suited for monitoring
CO continuously. In contrast, operator independent
techniques like oesophageal Doppler are not tolerated
well in the awake patient, which is an important limita-
tion in the intensive care setting. Bioimpedance techni-
ques have been evaluated, with results ranging from
acceptable to inconclusive [2]. Furthermore, bioreac-
tance techniques have been tested in a limited number
of clinical situations.
We recently developed a new technique for non-inva-
sive continuous cardiac output monitoring, which we
w i l lr e f e rt oa s‘Ventricular Field Recognition’,b a s e do n
measurement of spatial patterns of voltage changes dis-
tributed over the thoracic skin [3]. Basically, the Ventri-
cular Field Recognition method is based on the finding
that, if a weak electric current is applied over the thorax,
emptying and filling of the ventricles during the cardiac
cycle give rise to two-dimensional spatial patterns of
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any medium, provided the original work is properly cited.voltage changes on the thoracic skin, that are distinctly
different from the patterns due to filling and emptying
of the atria. This is caused by the fact that the ventricles
are situated at other locations inside the thorax than the
atria, and hence, the location of the ventricular “epicen-
ter” of the changes in the applied current field, due to
ventricular volume changes, differs from the location of
the atrial “epicenter” corresponding to atrial volume
changes. The changes in the applied current field, asso-
ciated with ventricular emptying, represent a particular
two-dimensional spatial pattern of voltage changes on
the thoracic skin, which we refer to as the ventricular
“fingerprint”. This ventricular fingerprint can be recog-
nized, and distinguished from the atrial fingerprint, pro-
v i d e dt h a tas u f f i c i e n tn u m b er of measuring electrodes
are distributed over the thoracic surface at the optimal
places.
Although our Ventricular Field Recognition method
depends on the differences in specific conductivity
between blood and other tissues, it is not based on
Impedance cardiography (ICG), but instead uses eight
independent and simultaneous voltage measurements to
probe the spatial distribution of voltages over the thor-
acic skin. Furthermore, unlike ICG or bioreactance-
based techniques [4], we retrieve the volume changes
(as a function of time during the cardiac cycle) of exclu-
sively the ventricles, instead of volume changes of the
entire heart [5]. In the current study we perfomed vali-
dation experiments in Dalland pigs against the gold
standard, an ultrasonic flow-probe around the ascending
aorta, under defined changes in loading conditions, car-
diac pacing and inotropic stimulation by dobutamine.
Materials and methods
Animals
All experiments were performed in accordance with the
“G u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i m a l s ”
prepared by the Institute of Laboratory Animal
Resources and with prior approval by the Animal
Experimentation Committee of the Faculty of Medicine,
Utrecht University, the Netherlands. The study was per-
formed on six Dalland Landrace pigs (IDDLO, Lelystad,
The Netherlands), in a weight range from 39 to 82 kg.
Anesthesia
T h r e ed a y sb e f o r et h es t a r to ft h ee x p e r i m e n tad a i l y
dose of 75 mg clopidogrel and a bolus of 500 mg acetyl-
salicylic acid was administered. After overnight fasting,
anaesthesia was induced using Ketamin (10 mg/kg),
midazolam (0.5 mg/kg), and atropin (0.04 mg/kg) and
additional thiopentone (5 mg/kg) immediately before
intubation. Muscle relaxation was achieved by bolus
injection of 0.1 mg kg
-1 pancuronium bromide. After
intubation, controlled positive pressure ventilation was
installed with (tidal volume 10 ml/kg, 12 breaths/min-
ute) an inspiratory oxygen concentration of 0.5. A
venous catheter was placed in an ear vein for continu-
ous administration of saline and anesthetic drugs.
Anesthesia was maintained by continuous infusion of
midazolam (1.0 mg · kg
-1 ·h
-1), and sufentanil citrate (2
μg·k g
-1 ·h
-1). In addition, pancuronium bromide was
administered continuously (0.1 mg · kg
-1 ·h
-1). Before
surgery, four times (with an interval of 15 minutes), a
bolus of 0.05 mg/kg propronolol was given.
Multi-electrode method to separate ventricular from atrial
filling
A set of nine electrodes was attached to the thorax,
according to a fixed scheme of electrode positions. The
relative positions of the nine electrodes have been opti-
mized in such a way that the ventricular volume-time
curve can be retrieved [3]. With the use of ultrasound
(Philips i33 Cardiograph, Philips Medical Systems, Eind-
hoven, The Netherlands) the contour of the heart was
estimated and drawn on the thoracic skin using a per-
manent marker. The “gauge point” (GP) on the skin was
defined as the position of the mitral valve projected on
the skin, estimated on the basis of the contour of the
heart on the thorax. Subsequently, each of the nine
measuring electrodes was placed on the thorax at a spe-
cific relative position with respect to the point GP, as
specified in Table 1.
Measuring equipment
The nine measuring electrodes mentioned above were
connected to the Hemologic Cardiac Profiler system,
which contains eight current source/demodulator units
based as described earlier in more detail [6,7], and a set
of two personal computers (PCs). One PC serves for
data acquisition and storage, and the second for data
processing and control. The current sources produce an
alternating current of 8 mApp at a fixed frequency in
the range between 55 kHz and 91 kHz. The current
injection can be selected to take place at both forelegs
and hind legs simultaneously or separately. The result-
ing voltage distribution on the thorax is measured by a
set of measuring electrodes, connected to the eight
demodulator systems mentioned above, which produce
eight independent input signals for the data-acquisition
computer. As a reference method to measure cardiac
output, a bi-directional ultrasonic flow probe was
attached around the ascending aorta, using a Transonic
T206 small animal flowmeter (Transonic Systems Inc,
Ithaca, New York, USA). The flowmeter output was
logged on to a notebook PC to enable accurate simulta-
neous comparison between calculated data from the
HCP and data obtained from the flowmeter. The HCP
produces one CO measurement every 20 seconds.
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During each session, the following steps were taken to
induce changes in cardiac output:
- Decrease in venous return induced by a vena cava
obstruction. For this purpose, a 3-0 prolene wire
(Ethicon Inc., Somerville, New Jersey, USA) was
placed around the vena cava. A step-wise decrease
of cardiac output, as monitored by the ultrasonic
flow-probe, could be obtained by step-wise tighten-
ing of the prolene wire.
- Increase in heart rate by external cardiac pacing
(Q-stim, Biosense Webster Inc., Diamond Bar, Cali-
fornia, USA) connected to the stimulator output of a
Physio-control Lifepack 9 defibrillator (Physio-con-
trol Inc., Redmond, Washington, USA.)
- Inotropic stimulation by administration of dobuta-
mine (5 μg/kg/minute b.w. i.v.)
Data acquisition and averaging
Each data point in the results section represents a single
period of 20 seconds. The HCP produces one single CO
value per 20 seconds, whereas the ultrasonic flow probe
(FP) produces beat-by-beat values. Therefore, the data
f r o mt h eF Pw e r ea v e r a g e dt op r o d u c eas i n g l eC Ov a l u e
per 20 seconds. Only data points that represented a
stable situation (that is, a constant CO value during 20
seconds) were incorporated into the data sets in the
Results section. During the vena cava obstruction experi-
ments, after each increase of the tightening of the prolene
wire, the experimenter waited until a stable CO value was
reached, and then recorded a single data point of 20 sec-
onds. For each of the six animals, seven different levels of
prolene wire tightening were used, resulting in 42 data
points from the vena cava obstruction experiments.
During the external cardiac pacing experiments, three
different heart rates were produced: 100 bpm, 120 bpm,
and 140 bpm. For each of these three heart rates, one data
point of 20 seconds was produced. For one specific animal,
o n es i n g l ed a t ap o i n tw a se x c l u d e db e c a u s et h i sa n i m a l
failed to endure cardiac pacing of 140 bpm. As a result,
the cardiac pacing experiments produced 17 data points
for six animals. During the inotropic stimulation experi-
ments with dobutamine, for each animal one data point
was recorded at each of the following three moments in
time: at one minute, at four minutes, and at seven minutes
after the start of the continuous dobutamine administra-
tion. One specific animal, however, failed to endure pro-
longed dobutamine administration and, subsequently, the
dobutamine administration was stopped after five minutes,
and, hence, no data point corresponding to seven minutes
of dobutamine administration was recorded for this speci-
fic animal. Therefore, 17 data points were recorded for the
dobutamine experiments for six animals.
For the total study, this amounts to 76 independent
data points. In both instances in which there was an
inability to obtain a data point, this was only due to the
condition of the animal.
Initial calibration
For each animal, an initial, once-only calibration of the
Hemologic Cardiac Profiler (HCP) was performed on
the basis of the readings of the invasive bi-directional
flow probe. The flow probe was calibrated on a regular
basis using an in-vitro set-up.
Statistical analysis
The study design was developed under the guidance of
the head of the Department of Statistics (Ingeborg van
de Tweel) for the Life Sciences of Utrecht University,
Table 1 Electrode positions, rendered as coordinates (X, Y) on the thoracic skin of the animal
Electrode # Position X (in mm)
Horizontal position (left-right)
with respect to Gauge Point (GP).
Orientation: The left-lateral side of the
thorax has positive X values
Position Y (in mm)
Vertical position (cranial-caudal)
with respect to Gauge Point (GP).
Orientation: The cranial end of the
thorax has positive Y values
1 24.5 9.1
2 -28.1 34.2
3 -36.0 -16.2
4 64.9 28.8
5 -59.5 46.8
6 -27.0 -81.1
7 -41.4 158.7
8 -9.0 -131.6
9 -86.5 61.3
The 2D positions of the electrodes are defined as relative distances with respect to the Gauge Point (GP). These relative distances are rendered as displacements
in the horizontal direction (X, left-right) and the vertical direction (Y, cranial-caudal), respectively, as measured along the (curved) thoracic skin. These nine
electrodes can be applied conveniently using a single compound electrode sticker, in which all electrodes are at their correct relative positions with respect to
each other.
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of the Faculty of Medicine, Utrecht University, The Nether-
lands. Pearson’s correlation was used to evaluate the corre-
lation between CO measurements from the HCP and CO
measurements from the ultrasonic flow-probe around the
ascending aorta. The fact that multiple measurement values
exist per animal, was taken into account by basing the cor-
relation coefficient and the 95% confidence intervals on
only the data points corresponding to the maximum inten-
sity stage of each type of manipulation (that is, maximal
tightening of the prolene wire during vena cava constric-
tion, maximum heart rate (140 bpm) during cardiac pacing,
and the longest period (seven minutes) of continuous dobu-
tamine administration), for each of the six animals. Further-
more, an additional regression plot was added, in which all
CO values was rendered as a percentage of the initial base-
line CO of each animal. As a result, the regression line
passes through (100,100). This enables rendering the 95%
confidence interval (95% CI) lines into the plot.
Furthermore, Bland-Altman analysis was used. Three
ranges of CO values were defined: (i) 0 to 2 L/minute,
(ii) 2 to 4 L/minute, and (iii) over 4 L/minute. For each
of these three ranges, bias and variability of the bias (2
standard deviations, 2SD), and lower and upper limits of
agreement, have been calculated. In these calculations,
the presence of multiple measurements per animal was
taken into account by using the Components of Var-
iance technique [8].
Furthermore, the performance of the new HCP system
was evaluated using four quality criteria proposed by
Squara et al. [9]: (i) bias, (ii) random error of measure-
ments of each modality of measurement (HCP and Flow
Probe), estimated by the variability (2SD) during a
steady-state situation at baseline level before the start of
the manipulations of the CO, (iii) response time, and
(iv) reliability for detecting directional changes.
For all changes larger than the overall SD, the direc-
tional changes were defined using the categories “con-
cordant” (changes in HCP and FP both larger than SD
and both pointing in the same direction), “discordant”
(changes in HCP and FP both larger than SD but point-
ing in different directions), false positive (change in
HCP larger than SD, but change in FP smaller than SD),
and false negative (change in HCP smaller than SD, but
change in FP larger than SD).
Results
Experiments were performed in six animals in the
w e i g h tr a n g ef r o m3 3k gt o8 2k g .A no v e r v i e wo ft h e
six animals is given in Table 2.
Measured cardiac output data
In total, 76 pairs of cardiac output measurements were
performed.
The coefficient of correlation between CO-HCP and
CO-FP was r = 0.978 (see Figure 1), and the slope was
1.045 (with 95% confidence interval from 0.96 to 1.14).
The coefficient of correlation and the 95% confidence
interval have been corrected for the multiple data points
per animal.
Bland-Altman analysis (Figure 2) showed a bias of -
0.28 L/minute and a variability of the bias (2SD) of 0.74
L/minute in the range of 0 to 2 L/minute, a bias of -
0.05 L/minute and a variability of the bias (2SD) of 0.31
L/minute in the range of 2 to 4 L/minute, and a bias of
0.02 L/minute and a variability of the bias (2SD) of 0.54
L/minute in the range above 4 L/minute. Lower limits
of agreement were -1.02 L/minute in the range of 0 to 2
L/minute, - 0.36 L/minute in the range of 2 to 4 L/min-
ute, and - 0.53 L/minute in the range above 4 L/minute.
Upper limits of agreement were 0.47 L/minute in the
range of 0 to 2 L/minute, 0.26 L/minute in the range of
2 to 4 L/minute, and 0.56 L/minute in the range above
4 L/minute.
For all data combined, mean bias was - 0.114 L/min-
ute (or -3.6%), variability of the bias (2SD) was 0.55 L/
minute (or 17.6%), lower limit of agreement was - 0.67
L/minute, and upper limit of agreement was 0.44 L/
minute.
For each of the manipulations, a separate plot was
produced with corresponding confidence intervals (95%
CI), see Figure 3.
Hemodynamic data during baseline conditions and the
maximum intensity stages of each manipulation are ren-
dered in Table 3.
Furthermore, the performance of the HCP system was
evaluated using four quality criteria proposed by Squara
et al. [9]: (i) Bias: overall bias was small (- 0.114 L/min-
ute, or -3.6%). (ii) Random error of measurements:d u r -
ing a steady-state situation at baseline level before the
start of the manipulations of the CO, the 2SD (preci-
sion) within the HCP data was assessed, as well as the
2SD within the FP data during the same period of time.
This resulted in 2SD = 0.33 L/minute for the HCP, and
2SD = 0.06 L/minute for the FP. Since the random error
of measurement of the FP is very small, and the CO
values produced by the FP are very close to the truth,
application of the errorgram method described by
Table 2 Animal overview
Animal # Type Gender Weight (kg) Age (weeks)
1 Dalland Pig Female 45,. 12
2 Dalland Pig Female 45 12
3 Dalland Pig Female 44 12
4 Dalland Pig Female 42.6 12
5 Dalland Pig Female 33 10
6 Dalland Pig Female 82 19
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by the reference technique yields virtually the same
answers as the 2SD of the HCP alone. (iii) Response
time is 27 seconds for the HCP: 20 seconds of data
acquisition followed by 7 seconds of automated data
processing leading to one single CO value. (iv) Reliabil-
ity for detecting directional changes: for all three
different manipulations, all CO changes exceeding 0.27
L/minute (the overall SD of the bias) have been ana-
lysed; see Table 4.
As an example, a series of data points from one single
animal (animal #3) has been rendered in Figure 4.
Discussion
The results of this validation study demonstrate that
cardiac output measures obtained with the Hemologic
Cardiac Profiler correlate well with measures obtained
with direct aortic blood flow measurements (the
accepted gold standard), after an initial calibration with
the reference method.
Comparison between HCP and ICG
A principal difference between the HCP and ICG or
bioreactance-based techniques, is that the HCP performs
a direct measurement of ventricular volume changes,
instead of total heart volume changes. Therefore, the
HCP, theoretically, provides a better basis for assess-
ment of stroke volume, because total heart volume var-
iation is not necessarily a reliable indicator of
ventricular stroke volume [5]. Furthermore, in compari-
son to ICG or bioreactance-based techniques, the HCP
may have, at least theoretically, the following advantage:
The voltage signal measured in every ICG system is
caused by the combined effects of volume changes in
different intrathoracic compartments during the cardiac
cycle, such as the intracardiac cavities, aorta, superior
and inferior vena cava, and pulmonary circulation. From
all these factors, ICG attempts to distill the stroke
volume using a single input voltage stream. From a
mathematical point of view, however, this single voltage
input stream is insufficient to balance the many
unknown variables inside the thorax. Some ICG-like
techniques (such as, for example, Woltjer et al. [10]) use
multiple electrodes, but - in contrast to our method -
still measure only one single voltage, because the leads
of many of these electrodes are interconnected to form
a single input channel. In contrast, with the new techni-
que (HCP), nine electrodes produce eight independent
and simultaneous voltage input streams, connected to
eight independent voltage demodulator units.
In this study, an initial calibration process using the
flow probe was performed for each animal, because of
the unknown attenuation of signals between the heart
and the skin due to inter-individual differences in thor-
acic wall thickness, (such as differences in thickness of
sub-cutaneous fat and muscle layers). In the future,
however, the HCP should be able to perform an auto-
calibration as a stand-alone technique [3]. In this auto-
calibration procedure, the measuring electrodes will be
used temporarily for current injection. In an in vitro
study and in computer models, we have shown that,
Figure 1 Collective results of the experiments on all six
animals.( a) Here, each CO value, produced by the new HCP
system at some moment in time during the experiments, is plotted
as function of the corresponding CO value as measured by the
invasive flow probe at the same moment in time. A trend line
(linear regression, solid red line) has been added; slope = 1.045
(95% CI is 0.96 to 1.14). Pearson’s correlation was r = 0.978. An
identity line (dotted thin line) has been added. (b) Same as a), but
now all CO values are rendered as a percentage of the initial
baseline CO value of each animal. This enables rendering of the
95% CI boundary lines (dashed green lines). Here, r = 0.972 and
slope = 1.062 (95% CI is 0.94 to 1.18).
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Page 5 of 8Figure 2 Bland-Altman plot of the collective results of all six animals. For each moment in time during the experiments that a cardiac
output value was produced by the HCP system, the difference between the CO, according to the HCP, and the CO, according to the flow
probe, was plotted as a function of the average of both CO’s at that moment. For each of three intervals along the x-axis (region 1: CO < 2 L/
minute; region 2: CO between 2 and 4 L/minute; region 3: CO > 4 L/minute), the bias is rendered (red solid line), along with the limits of
agreement (green dotted lines).
Figure 3 Regression plots for three methods of manipulating the cardiac output. a) Flow restriction in the vena cava inferior: r = 0.955,
slope = 1.02, and 95% CI is 0.92 to 1.12. b) Cardiac pacing: r = 0.982, slope = 1.06, and 95% CI is 0.95 to 1.17. c) Dobutamine administration: r =
0.981, slope = 1.01, and 95% CI is 0.95 to 1.07. For each of the three plots, a regression line (red solid line) has been added.
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fields, this procedure is capable of assessing the attenua-
tion of signals between the heart and the skin. There-
fore, in the future, this auto-calibration could potentially
take away the need for an initial calibration using ultra-
sound. Furthermore, recently a small modification of the
HCP has been developed that no longer needs the iden-
tification of a “gauge point” (GP) on the thorax and,
hence, eliminates the need for ultrasound to find the
heart contour. In future clinical studies, the autocalibra-
tion process and the GP auto- determination must be
validated.
We used direct aortic blood flow measurement of car-
diac output (CO-FP) as the gold standard. In contrast to
thermodilution cardiac output, direct aortic blood flow
measurement (CO-FP) has no relevant mean error, thus
the measured difference in cardiac output represents the
real difference. For all data combined, mean bias was -
0.114 L/minute (or -3.6%), and variability of the bias
(2SD) was 0.55 L/minute (or 17.6%.) Thus we can con-
clude that the mean error between a true reference
technique (ultrasonic flow probe around the aorta) and
the new technique demonstrates satisfactory validity.
Furthermore, we induced a number of variations in
cardiac output, which are either based on changes in
cardiac preload (venous inflow), or an increase in heart
rate and inotropy (ß-stimulation), to investigate the
agreement over a wide variation of CO-values. These
variations in cardiac output are common in the clinical
setting and the measurement technique should be able
to track them. Our data suggest that the validity of the
new technique is independent from the absolute cardiac
output value above absolute cardiac output values of
more than 2 L/minute. We observed a systematic under-
estimation (-0.28 L/minute, P < 0.05) of cardiac output
by the HCP in the range below 2 L/minute, as can be
seen from the regression line in Figure 1. Further analy-
s i so ft h ep e r f o r m a n c eo ft h eH C Pr e v e a l e dt h a tt h i s
underestimation in the range below 2 L/minute was
caused by sub-optimal positions of the thoracic electro-
des with respect to each other. In clinical practice, CO
values below 2 L/minute are not expected to happen in
the adult patient population.
Conclusions
In an animal model we demonstrated that the Hemolo-
gic Cardiac Profiler was able to track changes in cardiac
output. Therefore, we see a potential for this new tech-
nology to be useful in the clinical setting.
Key messages
￿ In an animal model we demonstrated that the new
technique of cardiac output monitoring (HCP) is
able to track changes in cardiac output.
￿ In contrast to impedance-based methods, the new
system (HCP) enables specific measurement of
changes in ventricular volume, instead of changes in
total heart volume.
￿ The HCP produces eight independent and simulta-
neous voltage input streams, connected to eight
independent voltage demodulator units. This enables
recognition of the effect of ventricular volume
changes in the applied field on the thoracic skin.
￿ An Ultrasonic Flow Probe (FP) around the aorta
was used as the gold standard.
￿ In a study on six pigs, Pearson’s correlation between
the CO-HCP and the CO-FP was r = 0.978. Bland-
Altman analysis showed a bias of - 0.114 L/minute,
and variability of the bias (2SD) of 0.55 L/minute.
Table 3 Hemodynamic data for six animals
Baseline Vena cava
constriction
(maximal)
Pacing
(140
bpm)
Dobutamine
(7 minutes)
HR (bpm) 54 ± 8 63 ± 11 140 ± 1 89 ± 14
MAP
(mmHg)
118 ±
17
96 ± 27 113 ± 23 138 ± 26
HR(bpm), heart rate (beats per minute); MAP(mmHg), mean arterial pressure
(millimeter of mercury). Data presented as mean ± standard deviation. Data
measured at baseline and at the maximum intensity of each of the three CO
manipulations.
Table 4 Ability of the HCP to track changes in cardiac output correctly, for each of the three methods of CO
manipulation
Type of manipulation Number of changes > SD Concordant* Discordant* False positive* False
negative*
Vena cava constriction 46 42 (91.3%) 1 (2.2%) 2 (4.3%) 1 (2.2%)
Cardiac pacing 4 3 (75.0%) 01 (25.0%) 0
Dobutamine 8 7 (87.5%) 01 (12.5%) 0
All manipulations combined 58 52 (89.6%) 1 (1.7%) 4 (6.9%) 1 (1.7%)
Only changes larger than the overall standard deviation (SD, 0.27 L/minute) have been considered, see subsection 2.8
(*): Data rendered as: number of points (percentage of total number of changes (> SD) in manipulation)
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Figure 4 Example of a series of data points from one single animal. In this graph, the results of the experiments on animal #3 are
rendered, showing the cardiac output as measured by the HCP (CO-HCP, dark blue diamonds), and as measured by the ultrasonic flow probe
(CO-FP, red dots). The enumeration of the experiments along the x-axis corresponds to the chronological order in which the measurements
have taken place on this animal. Thirteen independent data points have been collected. Data points #1 to #7 represent increasing levels of vena
cava constriction; data points #8 to #10 represent three levels of external cardiac pacing (at 100 bpm, 120 bpm, and 140 bpm, respectively), and
data points #11 to #13 represent the effects of one minute, four minutes, and seven minutes of continuous dobutamine administration,
respectively.
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